Demecan

Ebersbach, Germany · Founded 2017 · Privately Held (backing)

Producer and supplier of cannabis intended to be used for medicinal drug research and development process. Demecan is based in Ebersbach, Germany and was founded in 2017. Its last known valuation is $109 million. It has raised $23.4 million.

Last price · $/share
—
Implied valuation
$108.8M
Total raised
$23.4M
Last round
—
What is Demecan worth?
$108.8Mlast known valuation
Free account
More of Demecan with a free account
  • ·Watch Demecan: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Demecan funding history

No rounds on record

No funding rounds for Demecan are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Demecan valuation

Demecan's last known valuation is $109 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.

How Demecan's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Demecan, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about Demecan

What is Demecan worth?
Demecan's last known valuation is $108.8M.
How much has Demecan raised?
Demecan has raised $23.4M in total funding across its recorded rounds.